A Translational Study of Single Agent Olaparib in the Treatment of Advanced Oesophagogastric Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to AstraZeneca
Related studies linked through entity extraction aliases.
PD-L1 ImagiNg to prediCt Durvalumab Treatment Response in HNSCC
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Future Optimal Research and Care Evaluation
- Status
- RECRUITING
- Phase
- N/A
Ticagrelor Administered as Standard Tablet or Orodispersible Formulation
- Status
- COMPLETED
- Phase
- PHASE3
Durvalumab With Trastuzumab and Pertuzumab in HER2-Enriched Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Novel Anti-cancer Agents in Patients With Previously Untreated NSCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Disease Registry of Patients With Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- N/A
An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With Hyperkalaemia
- Status
- RECRUITING
- Phase
- PHASE3
A Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the Safety and Efficacy of Tezepelumab in Atopic Dermatitis
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Assess the Reaction of Body for Four Different Formulations of AZD9977 (Part A) and Influence of Food and Lower Dose of a Selected Formulation (Part B) in Healthy Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Assessment of Asthma Control Level in Primary Care Setting in Malaysia
- Status
- COMPLETED
- Phase
- N/A
Immunotherapy Combined With Y-90 and SBRT for Colorectal Liver Metastases
- Status
- WITHDRAWN
- Phase
- PHASE1
A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD9977 in Japanese Healthy Participants With Single and Multiple Ascending Dose Administration
- Status
- COMPLETED
- Phase
- PHASE1
AMTEC IIT: Phase 2 Multiarm Study in TNBC
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Safety,Tolerability,and Efficacy of VCN-01 With Durvalumab in R/M Head and Neck Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE1
First Real-world Data on Unresectable Stage III NSCLC Patients Treated With Durvalumab After Chemoradiotherapy
- Status
- COMPLETED
- Phase
- N/A
Prostate Cancer With OligometaSTatic Relapse: Combining Stereotactic Ablative Radiotherapy and Durvalumab (MEDI4736)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Benralizumab Pregnancy Exposure Study
- Status
- TERMINATED
- Phase
- N/A
Prevalence of PD-L1 Expression in Patients With Advanced Urothelial Carcinoma
- Status
- COMPLETED
- Phase
- N/A